Flixotide (fluticasone propionate) Accuhaler
Low carbon and now cheaper than the most commonly prescribed MDI and DPI ICS brands3
Not a healthcare professional? Visit our Public site
Not a healthcare professional? Visit our Public site
has been added to your basket
59
List price reductions for one SABA and three ICS packs from 1st August 2022
Flixotide (fluticasone propionate) Accuhaler Indication1
Flixotide Accuhaler offers preventative treatment for asthma.
For Adults: Prophylactic management in mild asthma for patients requiring intermittent symptomatic bronchodilator asthma medication on a regular daily basis; prophylactic management in moderate asthma for patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone; prophylactic management in severe asthma for patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms.
For children: Any child who requires prophylactic medication for asthma, including patients not controlled on currently available prophylactic medication.
Ventolin (salbutamol) Accuhaler Indication2
Ventolin Accuhaler is indicated in adults, adolescents and children aged 4 to 11 years. Ventolin Accuhaler can be used in the management of asthma, bronchospasm and/or reversible airways obstruction.
Flixotide Prescribing Information (PDF)
References
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441
© 2021 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.
July 2022 | PM-GB-FLP-WCNT-220001 (V1.0)